ENvue Medical (FEED)
Electromagnetic feeding-tube navigation systems and therapeutic-ultrasound devices.
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
TYLER, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced it has been selected to exhibit its ENvue™ Navigation Platform, a minimally invasive electromagnetic navigation system guiding feeding tube placement, at the Vizient® Innovative Technology Exchange.
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into a securities purchase agreement (“ELOC”) with an institutional investor providing the Company with an equity facility for up to $50 million in capital (the “Facility”), subject to the terms and conditions of the agreement, including the receipt of stockholder approval.
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
Additional Platform Deployment at Major Academic Medical Center Reflects Increasing Commercial Demand for Bedside Feeding Tube Navigation Additional Platform Deployment at Major Academic Medical Center Reflects Increasing Commercial Demand for Bedside Feeding Tube Navigation
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing Amdocs AI Governance Leadership and $320 Million in Executed Financings and M&A, Respectively TYLER, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that Zeev Rotstein, M.D.
Envue Medical Expands AI Navigation Platform With Robotic Prototype
ENvue Medical, Inc. (NASDAQ:FEED) announced Thursday the development and demonstration of the prototype of ENvue Drive.
ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool
ENvue Targeting Combined $10 Billion+ Enteral Feeding and Vascular Access Market Opportunity* ENvue Drive™ Demonstration Marks First Step Toward a New Generation of Intelligent Bedside Procedures and Integrates ENvue's Proprietary AI Navigation Software, Ask Oscar™ TYLER, Texas, July 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced the successful development and demonstration of the first prototype of ENvue Drive™, which the Company believes is the first next-generation robotic-assisted tool built within the ENvue electromagnetic navigation platform ecosystem, designed to integrate artificial intelligence, real-time navigation, and robotic-assisted procedural execution into a unified clinical workflow. A demonstration video highlighting the ENvue Drive prototype, including integrated navigation, artificial intelligence, and robotic-assisted advancement capabilities, is available here: http://envue.com/ask-oscar/#video.
Brazil Potash Awards Front End Engineering Design (FEED) Contract For Mine Shafts and Underground Development to WSP UK Ltd., with Redpath Deilmann Mining Inc. as Subconsultants, Completing Full-Project FEED Coverage at Autazes
MANAUS, Brazil, June 17, 2026 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE-American: GRO), a mineral exploration and development company advancing the Autazes potash project in Amazonas State, Brazil (the “Autazes Project” or “Project”), is pleased to announce the award of a second Front-End Engineering Design (“FEED”) contract for mine shafts and underground development to WSP UK Ltd., with Redpath Deilmann (“Redpath”) as subconsultants for the mine shafts scope.
Ohmium and Hynfra Sign Master Cooperation Agreement to Advance Large-Scale Green Hydrogen Projects in the Middle East and Africa
NEWARK, Calif. & WARSAW, Poland--(BUSINESS WIRE)-- #EnergyIndependence--Ohmium International Inc., a leading manufacturer of high-efficiency, modular Proton Exchange Membrane (PEM) electrolyzers, and Hynfra P.S.A., a prominent green hydrogen and green ammonia project developer, today announced the signing of a master cooperation agreement to advance green hydrogen projects in Mauritania, Jordan, and Oman. The cooperation agreement covers the projects' Front-End Engineering and Design (FEED) stage and establishes the.
ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
AI-based platform, ‘Ask Oscar™', to accelerate adoption of ENvue's Navigation Platform and enable clinicians to train independently and reduce implementation barriers
ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging
ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026
TYLER, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that the Company will participate as an exhibitor at the American Association of Critical Care Nurses National Teaching Institute & Critical Care Exposition (“AACN NTI”) 2026, taking place May 21–22, 2026. Recognized as the largest critical care nursing conference in the United States, AACN NTI brings together thousands of frontline nurses, nurse leaders, educators and healthcare professionals from leading hospitals and healthcare systems nationwide.
ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care
ENvue™ Navigation Platform adopted as the standard of care for bedside feeding tube placement across the integrated health network ENvue™ Navigation Platform adopted as the standard of care for bedside feeding tube placement across the integrated health network
ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology
Patent Expands Company's Proprietary Surface Acoustic Wave Platform into Advanced Therapeutic Delivery Applications Patent Expands Company's Proprietary Surface Acoustic Wave Platform into Advanced Therapeutic Delivery Applications
ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals
Renewed agreement provides streamlined access to ENvue equipment and supplies across a network of more than 90 hospitals in 17 states Renewed agreement provides streamlined access to ENvue equipment and supplies across a network of more than 90 hospitals in 17 states
Brazil Potash Awards Front-End Engineering Design (FEED) Contract for Surface Facilities and Infrastructure to Wood and Promon Engenharia, Advancing Bankability of the Autazes Project
MANAUS, Brazil, May 06, 2026 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE-American: GRO), a mineral exploration and development company advancing the Autazes potash project in Amazonas State, Brazil (the “Autazes Project”), is pleased to announce the award of a Front-End Engineering Design (“FEED”) contract for the processing plant, tailings facility, river barge port, and the upgrade of approximately 13 km of road connecting the plant to port, to a consortium of Wood and Promon Engenharia (“Promon”).
ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network
Regional hospital transitions feeding tube procedures from interventional radiology to bedside nursing care using the ENvue™ Navigation Platform Regional hospital transitions feeding tube procedures from interventional radiology to bedside nursing care using the ENvue™ Navigation Platform
Head to Head Comparison: Nanovibronix (NASDAQ:FEED) versus CapsoVision (NASDAQ:CV)
CapsoVision (NASDAQ: CV - Get Free Report) and Nanovibronix (NASDAQ: FEED - Get Free Report) are both small-cap manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk. Profitability This table compares CapsoVision and Nanovibronix's net margins,
What's Going On With ENvue Medical Stock On Thursday?
ENvue Medical Inc. (NASDAQ: FEED) shares are down during Thursday's premarket session after the stock surged around 17% on Wednesday.
Financial Contrast: Nanovibronix (NASDAQ:FEED) and Medline (NASDAQ:MDLN)
Medline (NASDAQ: MDLN - Get Free Report) and Nanovibronix (NASDAQ: FEED - Get Free Report) are both manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends. Profitability This table compares Medline and Nanovibronix's net margins, return